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Background
Type 2 diabetes mellitus (T2DM) is a metabolic disorder that is caused by the interac-
tion of genetic and environmental factors. Neuropeptide Y (NPY) is a potent appetite-
stimulating hormone that mainly comes from the hypothalamic arcuate nucleus (ARC) 
(Sousa-Ferreira et al. 2011), which plays a pivotal role in regulating of feeding behavior 
and energy consumption. Pathophysiologically, type 2 diabetes mellitus is characterized 
by hyperinsulinemia and insulin resistance. Insulin can act locally to inhibit the synthe-
sis and release of hypothalamic NPY (Maejima et  al. 2011). Ghrelin is predominantly 
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produced by the gastric mucosa, which stimulates the appetite and induces a positive 
energy balance leading to body weight gain (Kirsz and Zieba 2011). Leptin is secreted 
principally by the adipocytes of the white adipose tissue and can curb the appetite and 
reduce the formulation and accumulation of fat, both of which are closely associated 
with the occurrence of type 2 diabetes mellitus (Zhang et al. 2013). Moreover, NPY-pos-
itive cells located in hypothalamic ARC are the site of action for both ghrelin and leptin. 
Ghrelin stimulates the synthesis and secretion of NPY, whereas leptin inhibits it (Druce 
and Bloom 2012). During the development of the type 2 diabetes mellitus rat model, the 
changes in hypothalamic NPY contents and its correlation with the insulin, leptin, and 
ghrelin levels, as well as the potential mechanism underlying their interactions have not 
yet been reported. This study aimed to investigate the changes of hypothalamic NPY lev-
els and the main hormones that regulate the synthesis and release of hypothalamic NPY, 
including insulin, leptin, and ghrelin, and may provide additional insights into the study 
of the pathogenesis of type 2 diabetes.
Methods
Animal grouping and model preparation
Seventy male Sprague–Dawley rats (6 weeks of age) with a mean body weight of 200 g 
were provided by the Laboratory Animal Center of Hebei Medical University, China 
(Certificate Number: DK0408-0089). All rats had free access to food and water and 
were given 1  week to adapt to the new environment before any procedures was initi-
ated. Of them, 10 rats assigned to the control group were fed with standard laboratory 
chow. The remaining 60 rats were assigned to the experimental group and fed a high-fat 
(HF) diet (10% more lard and 2% more cholesterol than the standard laboratory chow). 
After being fed a high-fat diet for 4 weeks, the rats in the experimental group were then 
subdivided into 2 groups according to body weight: 31 rats with a body weight of more 
than 2 standard deviations (g) above the mean weight of the controls were classified as 
the diet-induced obese (DIO) rats and selected for further study, whereas the 29 rats 
with body weights below this threshold were excluded. Ten of the 31 (DIO rats were 
killed and their blood serum and brain tissue were harvested, and this group was set as 
the DIO4W group. The remaining 21 DIO rats were allowed to continue eat a high-fat 
diet for another 4 weeks, and then 10 rats were killed to collect blood and brain tissue 
samples at the end of the feeding trial (at the eighth week), and this group is referred 
to as the DIO8W group. The remaining 11 rats were intraperitoneally injected with STZ 
(25 mg/kg) for 10 days. At the end of the STZ treatment, all 11 rats had fasting blood 
glucose (FBG) more than 3 standard deviations (g) above the mean levels of the con-
trols (7.8 mmol/l) were classified into T2DM group. Therefore, type 2 diabetes mellitus 
models were successfully established in all of the 11 rats. Thus, the experimental animals 
were divided into 4 groups: control, DIO4W, DIO8Wp, and T2DM groups. We used glu-
cose clamp technology and the insulin sensitivity index (ISI) to evaluate insulin sensitiv-
ity in each group.
Determination of general physical characteristics
General physical characteristics of rats, including appetite, behavior, hair, and excre-
ment, were recorded every day. Body length and body weight were measured weekly and 
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Lee’s index [Lee’s index = (weight of 1/3 × 1000)/body length (cm)] employed as a pre-
dictor of obesity in the MSG-rodents, was calculated. The fasting blood glucose levels 
were monitored. All fat located within the abdominal cavity was removed and their wet 
weight was determined afterwards. The serum total cholesterol and triglycerides were 
determined using a BeckmanX-20 automatic biochemical analyzer.
Biochemical analysis
The rats were anesthetized with an intraperitoneal injection of 2.5% sodium pentobar-
bital (50 mg/kg). The 4 ml samples of blood were taken by heart puncture at the time 
of death (2 ml with anti-coagulant treatment, and 2 ml without coagulant treatment). 
Blood samples were centrifuged at 1600  rpm at 4  °C for 15  min, and serum (plasma) 
was stored at −70 °C for further assays. Serum levels of insulin and leptin were deter-
mined by radioimmunoassay using a commercial kit (intra-assay CV < 10%, inter-assay 
CV  <  15%) from Beijing Hi-Tech Atomic Technology, Inc. (Beijing, China). Samples 
within a given matched set were assayed in the same batch by laboratory personnel 
who were blinded to the case or control status of the serum sample using a FJ-2021 γ 
radioactivity counter. In addition, plasma ghrelin concentrations were measured with a 
MK-Ascent microplate reader using enzyme-linked immunosorbent assay (ELISA) kit 
(Phoenix Pharmaceuticals, Inc., Burlingame, CA, USA).
Hypothalamic NPY determination
The NPY levels in the hypothalamus were measured with specific radio immunological 
assays. The rats were killed and intracardially perfused with normal saline before decapi-
tation. Subsequently, the brain tissues were boiled in 0.2 mol/l of acetic acid solution for 
10 min to inactivate the enzyme. The hypothalamus was dissected and homogenized fol-
lowing an additional 1 ml of the acetic acid solution. After homogenization, the solution 
was centrifuged and the resulting supernatant was collected for further analysis. The above 
mentioned procedures were performed in accordance with the kit’s instructions. The kits 
were obtained from Shanghai Ruiqi Biological Technology Co. Ltd.(Shanghai, China).
Determination of NPY mRNA, OB‑Rb mRNA, and GHS‑R1a mRNA
Total RNA was extracted from hypothalamic tissue using the TRIzol reagent (Invitro-
gen, Carlsbad, CA, USA) in 100 mg of tissue according to the manual. The tissues were 
re-dissolved in each tube with 20 μl of 0.1% DEPC-treated water. The RNA preparations, 
which had ratio of OD260/OD280 in the range of 1.8–2.0 determined by 756 UV–VIS 
Spectrophotometer, were regarded as pure and used for reverse transcription. Reverse 
transcription was performed with 2 µg of isolated total RNA at 42 °C using reverse tran-
scription kit (MBI Fermentas, USA). Semi-quantitative polymerase chain reaction (PCR) 
amplification was employed to investigate the tissue distribution of NPY mRNA, OB-Rb 
mRNA, and GHS-R1a mRNA in the hypothalamic tissue. For normalization, β-actin 
levels were used as an internal control. PCR in the exponential amplified stage with 35 
cycles of amplification was selected for NPY, OB-Rb, GHS-R1a and β-actin. The primers 
of NPY, GHS-R1a, OB-Rb and β-actin were all synthesized by Shanghai Biological Engi-
neering Co., Ltd. The detailed thermal cycling conditions for PCR are shown in Table 1. 
Finally, RT-PCR products were separated by electrophoresis and differential display of 
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RT-PCR gels were analyzed for quantification using a UVP imaging system. The relative 
mRNA expression of the target genes was calculated by the ratio of the OD value of the 
target band to that of the internal control band.
Statistical analysis
Statistical analysis was performed with SPSS software (version 10.0). Central tendency 
and dispersion tendency were expressed as the means and standard deviation. ANOVA 
was used to test the differences among groups. The t test was employed for pair wise 
comparison, and linear regression/correlation analysis was performed to evaluate the 
interrelationship between parameters. The correlation analysis was carried out in 2 
stages. In the first stage, each explanatory variable was tested using the Pearson coef-
ficient. Then, the variables that reached a significant association at the 5% level were 
included in a multiple linear regression model. A P value of less than 0.05 was accepted 
as significant for all analyses in the study.
Results
General physical characteristics
The rats in the control group had lustrous hair and were lively, while the rats in the DIO 
group showed mild physical and mental sluggishness movement slowness, lower and 
softer fecal excretion as well as chunky and obese figures as compared with the control 
group. Further, in the T2DM group, the rats displayed obvious mental sluggishness and 
increased frequency of urination, drinking, and eating (Table 2). The body weight, length 
and Lee’s index and insulin resistance index of rats in each group are listed in Table 3. 
During the development of the type 2 diabetes mellitus rat model, the body weight and 
Lee’s index of the rats displayed an upward trend (P < 0.01). The GIR and ISI displayed 
a downward trend (P < 0.01). The body weight and Lee’s index of the DIO4W, DIO8W, 
Table 1 Primer sequences and PCR thermal cycle parameters
Target gene Primer sequence PCR thermal cycle parameters
NPY (386 bp) 5′CAGAGCACCAGAAAGCCCAGCAG 3′
5′ CCAACATCGAAGGGAGCATTGAA 3′
95 °C 10 min, 95 °C 5 s, 57 °C 10 s,
72 °C 30 s (35 cycles), 72 °C extended 5 min
GHS‑R1a (313 bp) 5′GAGATCGCTCAGATCAGCCAGTAC3′
5′TAATCCCCA AACTGAGGTTCTGC3′
94 °C 5 min, 94 °C 45 s, 53 °C 40 s,
72 °C 45 s (35 cycles), 72 °C extended 5 min
OB‑Rb (116 bp) 5′ GCAGCTATGGTCTCACTTCTTTTG 3′
5′ GGT TCC CTG GGT GCT CTG A 3′
94 °C 5 min, 94 °C 45 s, 52 °C 40 s,
β‑actin (409 bp) 5′ GCC ATG TAC GTA GCC ATC CA 3′
5′ GAA CCG CTC ATT GCC GAT AG 3′
72 °C 45 s (35 cycles), 72 °C extended 5 min
Table 2 The characteristics for each group at the end of experiment (x¯ ± s)
* P < 0.01 when compared with the controls
△ P < 0.01 as compared with the DIO4W and DIO8W groups
Groups n Water intake (ml/day) Food intake (g/day) Urine volume (ml/
day)
Control 10 24.00 ± 1.52 16.12 ± 0.79 20.12 ± 1.17
DIO4W 10 35.29 ± 2.88* 19.88 ± 0.72* 33.44 ± 1.57*
DIO8W 10 68.37 ± 5.70* 24.43 ± 1.06* 59.72 ± 6.36*
T2DM 11 186.13 ± 4.37* 28.90 ± 0.75*△ 144.12 ± 7.00*
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and T2DM groups were increased by 55.6, 105.4 and 109.8%, respectively, while the cor-
responding increases in the control group were 3.94, 6.63 and 6.90%, respectively. The 
GIR of the DIO4  W, DIO8  W and T2DM groups were decreased by 80.15, 60.74 and 
49.12%, respectively, compared with control group. The ISI were decreased by 3.55, 9.77 
and 25.33%, respectively. The extent of elevation in the T2DM group was lower than 
those in the DIO4W and DIO8W groups.
Adipose tissue and blood lipids
During the development of the T2DM model, the wet weight of the adipose tissue in the 
rats in the experiment groups was raised in a time-dependent manner, which increased 
respectively by 239, 366 and 418%, respectively, in rats of the DIO4W, DIO8W and T2DM 
groups compared with the control group (P < 0.01).
During the establishment of the type 2 diabetes mellitus rat model, the total serum 
cholesterol and triglyceride of the rats demonstrated an increasing trend (P < 0.01). As 
compared with the controls, the serum cholesterol levels were elevated by 196, 289 and 
365% in the DIO4W, DIO8W and T2DM groups, respectively, and the serum cholesterol 
contents were increased by 158, 242, and 347%, respectively (Fig. 1).
Fasting blood glucose, serum insulin, serum leptin, and plasma ghrelin levels
The fasting blood glucose levels in the DIO4W and DIO8W groups were similar to that of 
the control group (P > 0.05).Nevertheless, the fasting blood glucose levels in the T2DM 
group was significantly higher than that of the controls (9.71 ± 1.56 mmol/l) (P < 0.01). 
The concentrations of fasting serum insulin in the DIO4W and DIO8W groups were 
elevated in a time-dependent pattern as compared with the control group (P  <  0.01), 
whereas lower fasting insulin levels were found in the T2DM group compared with that 
in the DIO8W group (P < 0.01) (Table 4; Fig. 2).
Table 3 Changes in body weight, length, and Lee’s index (x¯ ± s)
* P < 0.01 when compared with the controls
Group n Body weight (g) Body length (cm) Lee’s index GIR (mg/kg/min) ISI
Control 15 205.23 ± 10.05 18.38 ± 0.67 320.92 ± 7.35 10.22 ± 0.04 −4.50 ± 0.13
DIO4W 15 319.29 ± 11.89* 20.49 ± 0.86 333.57 ± 11.79* 8.19 ± 0.09* −4.66 ± 0.08*
DIO8W 15 421.45 ± 14.09* 21.91 ± 0.97* 342.19 ± 14.10* 6.99 ± 0.10* −4.94 ± 0.12*
DM 15 430.48 ± 15.13* 22.01 ± 1.05* 343.06 ± 7.35* 5.02 ± 0.06* −5.64 ± 0.10*
Fig. 1 Changes in blood lipids and celiac fat weight
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Increasing levels of the fasting serum leptin was observed from the control group to 
the T2DM group (P < 0.01). The concentrations of fasting plasma ghrelin in the DIO4W 
and DIO8W groups decreased in a time-dependent fashion as compared with the control 
group (P < 0.01); however, no significant difference was found between the DIO8W and 
the T2DM groups (P > 0.05).
Hypothalamic NPY contents and NPY mRNA expression
Hypothalamic NPY content
The hypothalamus NPY contents were 133.4  ±  17.1 (pg/ml) in the normal control 
group, and were 160.9 ± 21.7, 194.8 ± 37.0, and 251.1 ± 40.9 (pg/ml), respectively in 
the DIO4W, DIO8W, and T2DM group. With the development of the type 2 diabetes mel-
litus rat model, the hypothalamic NPY content increased in a time-dependent manner 
in the rats (P < 0.01). Compared with the normal control group, the hypothalamic NPY 
levels increased by 20.6, 46.0, and 88.2%, respectively, in the DIO4W, DIO8W, and T2DM 
groups (the differences between the 2 adjacent groups were 20.6, 21.1, and 28.9%).
Hypothalamic NPY mRNA expression
With the development of the type 2 diabetes mellitus model in rats, the expression 
of hypothalamic NPY mRNA showed a time-dependent increase. The OD values of 
NPY mRNA expression for the DIO4W, DIO8W and T2DM groups were 1.15  ±  0.16, 
1.51 ± 0.14 and 1.78 ± 0.14, respectively, all of which were significantly higher than that 
of the control group (0.86 ± 0.14, P < 0.01) (Fig. 3).
Hypothalamic GHS‑R1a and OB‑Rb mRNA
The OD values of the GHS-R1a mRNA were 1.38 ± 0.12, 1.29 ± 0.14, 0.94 ± 0.17 and 
0.76 ± 0.16, and also showed a downward trend (P < 0.01) (Fig. 4). The OD values of the 
Table 4 Fasting blood glucose, serum insulin and leptin and plasma ghrelin levels (x¯ ± s)
* P < 0.01 when compared with the controls
△ P < 0.01 as compared with the DIO8W group
Groups n FBG (mmol/l) Insulin (IU/ml) Leptin (ng/ml) Ghrelin (ng/ml)
Control 10 5.35 ± 0.29 15.23 ± 1.65 0.26 ± 0.03 2.01 ± 0.24
DIO4W 10 5.42 ± 0.33 21.36 ± 1.79* 0.32 ± 0.04* 1.86 ± 0.36*
DIO8W 10 5.59 ± 0.30 28.28 ± 1.89* 0.39 ± 0.05* 1.63 ± 0.33*
T2DM 11 9.69 ± 1.56* 23.34 ± 1.59*△ 0.46 ± 0.06* 1.60 ± 0.24*
Fig. 2 Fasting blood glucose, serum insulin and leptin, and plasma ghrelin levels
Page 7 of 10Zhang et al. SpringerPlus  (2016) 5:1913 
OB-Rb mRNA expression in hypothalamus in the control, DIO4W, DIO8W, and T2DM 
groups were 29.15 ± 7.96, 14.89 ± 4.98, 5.96 ± 2.12 and 5.61 ± 1.13, respectively, which 
showed a downward trend (P < 0.01) (Fig. 5).
Correlation analysis
The contents of hypothalamic NPY in all of the groups were positively associated with 
the fasting serum insulin (r = 0.892, r2 = 0.793, P < 0.01) and leptin levels (r = 0.951, 
r2 = 0.905, P < 0.01). Nevertheless, it was inversely correlated with the fasting plasma 
ghrelin levels (r = −0.888, r2 = 0.789, P < 0.01).
Fig. 3 RT‑PCR analysis of hypothalamic NPY mRNA expression. NPY mRNA were detected during the devel‑
opment of the T2DM in a rat model, based on which the rats were divided into 4 groups: normal control (NC), 
DIO4 W (fed a high‑fat diet for 4 weeks), DIO8 W (fed a high‑fat diet for 8 weeks) and T2DM group (fed a high‑
fat diet for 8 weeks + STZ intraperitoneal injection). NPY mRNA increased significantly in a time‑dependent 
fashion: The OD values of NPY mRNA expression for the DIO4 W, DIO8 W, and T2DM groups were significantly 
higher than that of the control group (P < 0.01). *P < 0.05 vs. NC group
Fig. 4 RT‑PCR analysis of hypothalamic GHS‑R1a mRNA expression. The expression of GHS‑R1a mRNA was 
detected respectively in normal control group (NC), DIO4 W group (feed on high fat diet for 4 weeks), DIO8 W 
group (fed a high‑fat diet for 8 weeks), and T2DM groups (fed a high‑fat diet for 8 weeks +STZ intraperitoneal 
injection), respectively. The OD values of the GHS‑R1a mRNA expression in hypothalamus in the control, 
DIO4 W, DIO8 W, and T2DM groups were 1.38 ± 0.12, 1.29 ± 0.14, 0.94 ± 0.17 and 0.76 ± 0.16 respectively, 
which showing a downward trend (P < 0.01). *P < 0.05 vs. NC group
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Discussion
In the present study, the conventional type 2 diabetes mellitus rat model protocol was 
modified (Zhang et al. 2010) by administering intraperitoneal injection of small doses of 
STZ (30 mg/kg) to the DIO rats instead of the high-fat diet rats. The modified procedure 
may produce a type 2 diabetes mellitus rat model that can better mimic the occurrence 
and development of human type 2 diabetes mellitus, with the existence of peripheral 
insulin resistance and mildly impaired pancreas function, which causses a stable insu-
lin resistance. Therefore, this procedure is more in line with the pathogenesis of human 
type 2 diabetes mellitus.
Several indexes, such as body weight, Lee’s index, and fat wet weight were measured 
to determine the obesity and fat accumulation of the laboratory animals. The results 
showed that during the establishment of the type 2 diabetes mellitus rat model, all of the 
above mentioned indicators presented an increasing trend, which confirmed that obe-
sity can be induced by a high-fat diet in a quite short term. However, the magnitude of 
weight gains in the DIO8W group was lower than that in the DIO4W group; part of the 
reason for this phenomenon may lie in the occurrence of diabetes.
This study confirmed that during the development of a type 2 diabetes mellitus rat 
model (from the control group to the T2DM group), the expression of the hypothalamic 
neuropeptide Y increased in a time-dependent manner as the body weight and body fat 
elevated, which is consistent with the reports of the previous studies (Polkowska et al. 
2012). Therefore, neuropeptide Y serves as the most potent appetite stimulator, which 
can reduce energy consumption and may play a key role in the onset of both obesity and 
type 2 diabetes mellitus (Parker and Bloom 2012).
The neuropeptide Y system is considered to be the final common pathway for appetite 
expression in the hypothalamus. Leptin is an appetite-suppressing peptide, while ghrelin 
is an appetite-stimulating one. They antagonize each other in regulating energy balance 
(Yang et al. 2010), and regulate appetite and eating behavior by directly signaling to the 
hypothalamic neuropeptide Y neurons. Moreover, insulin is another important hormone 
Fig. 5 RT‑PCR analysis of hypothalamic OB‑Rb mRNA expression. The OD values of the OB‑Rb mRNA were 
29.15 ± 7.96, 14.89 ± 4.98, 5.96 ± 2.12 and 5.61 ± 1.13 in the normal control (NC), DIO4 W (fed a high‑fat 
diet for 4 weeks), DIO8 W group (fed a high‑fat diet for 8 weeks), and T2DM groups (fed a high‑fat diet for 
8 weeks + STZ intraperitoneal injection), and also showed a downward trend (P < 0.01). *P < 0.05 vs. NC 
group
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that can regulate hypothalamic neuropeptide Y secretion, and increased insulin secre-
tion can inhibit the synthesis and release of the hypothalamic neuropeptide Y (Martins 
et al. 2012; Fick and Belsham 2010; Duarte et al. 2012).
The results demonstrated that serum insulin and leptin levels increased, whereas 
plasma ghrelin concentration decreased with the increase of body weight and body fat 
in the DIO4W and DIO8W groups when compared with the controls during the develop-
ment of type 2 diabetes mellitus model in rats, which was consistent with the results 
of our previous research on high-fat diets and STZ-induced type 2 diabetes mellitus 
in rats (Briggs et al. 2010). Plasma insulin and leptin enters the central nervous system 
though the blood brain barrier and interacts with the specific insulin and the receptor 
of leptin (OB-Rb) receptors in the hypothalamic ARC, thereby suppressing the hypo-
thalamic ARC NPY expression and curbing food intake (Laron 2009). Ghrelin binds 
to and activates GH secret agogue receptor type 1a (GHS-R1a), thus stimulating the 
NPY expression and promoting food intake (Morton and Schwartz 2011). Neverthe-
less, insulin resistance and leptin resistance was induced by high-fat diet in the DIO rats 
(Kirsz and Zieba 2011). On the one hand, it led to the abnormal transport through the 
blood–brain barrier of leptin and insulin, leading to decreased levels of insulin and lep-
tin in the CNS despite of the existence of hyperinsulinemia and hyperleptinemia. On 
the other hand, it might result in receptor and post-receptor defects and block normal 
signal transduction, especially for inhibitory effect of insulin and leptin on hypotha-
lamic ARC NPY expression, leading to elevated NPY levels in hypothalamus. Leptin is 
a powerful inhibitor of ghrelin (Verhulst et al. 2012), which can act directly on gastric 
mucosa to inhibit ghrelin release. In addition, increased insulin secretion can suppress 
the plasma ghrelin concentration as well (Andrews 2011). Thus, during the development 
of the type 2 diabetes, increasing serum concentrations of insulin and leptin, decreasing 
plasma ghrelin, and declining ghrelin’s stimulation on hypothalamic ARC NPY neurons 
were observed from the control group to the DIO8W group. It has to be mentioned that 
the hypothalamic NPY neurons were innervated by several types of hormones, and the 
mechanisms by which the NPY concentrations somehow remained high need to be fur-
ther explored. Generally speaking, the decrease in plasma ghrelin concentrations can be 
regarded as the body’s negative feedback regulation in response to the positive energy 
balance, by which appetite and food intake can be inhibited and further weight gain may 
be prevented.
Hyperleptinemia persisted from the DIO8W group to the T2DM group throughout the 
experiment. Nevertheless, the serum insulin levels in the T2DM group were lower than 
that in the DIO8W group, which might be attributed to the fact that STZ can directly 
damage the pancreas following intraperitoneal injection, leading to a consequent sharp 
decrease in insulin secretion (Briggs et al. 2010). Central insulin levels might decrease 
with the reduction in peripheral insulin levels as well, which further weakens its inhibi-
tory effect on the NPY neurons in the hypothalamus ARC. As a result, the contents of 
hypothalamic NPY increased significantly (up to 28.9%). Furthermore, after completion 
of the type 2 diabetes mellitus model, the concentrations of fasting plasma ghrelin did 
not continue to decrease. It might due to the weakened inhibition influence of insulin 
on ghrelin following the significant reduction of serum insulin concentrations, and the 
increased plasma ghrelin further boosted the expression of hypothalamic NPY.
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These results are consistent with those of our previous studies (Zhang et  al. 2013) 
and suggest that both the hypothalamic OB-Rb and GHS-R1a mRNA expression were 
reduced with the development of the type 2 diabetes mellitus rat model. The findings 
suggest that the reduced expression of OB-Rb mRNA is another pivotal mechanism 
underlying leptin resistance in addition to the abnormal blood–brain transport of lep-
tin. Furthermore, the decreased GHS-R1a mRNA expression is believed to be related to 
ghrelin resistance (Briggs et al. 2010).
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